Clinical trials
Acute Hospitalization clinical trials
Below are recruiting acute hospitalization clinical trials, each written for real people, not researchers. We’re tracking 983 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06065150Recruiting
Early surgery vs 3-day waiting for bowel blockage
This trial compares two approaches for a sudden blockage in the small intestine caused by scar tissue: having surgery right away versus waiting up to three days with non-surgical care. It aims to see which approach leads to better outcomes, so you and your doctor can make a more informed choice.
AmiensAges 18 years+ - NCT06081218Recruiting
Exercise and brain function in cannabis users
This study looks at how a single session of exercise affects brain function and memory in regular cannabis users compared to non-users. You will exercise on a bike or watch a movie, and then do memory tests and a blood draw.
LilleAges 18–35 - NCT06182943Recruiting
Electroacupuncture for recent mild to moderate ankle sprains
This study tests whether a type of acupuncture with mild electrical current (electroacupuncture) can help heal a fresh, mild-to-moderate ankle sprain. You may be eligible if you sprained your ankle within the last 48 hours, have no broken bones, and do not have serious health issues.
Hangzhou, ZhejiangAges 18–60 - NCT04937699RecruitingPhase 4
Switching anti-platelet tablets after a heart stent
This trial studies whether changing the timing and type of blood-thinner tablets after a heart stent is as safe and effective as continuing the same plan. It may help some people by simplifying treatment while preventing dangerous clotting after a coronary procedure.
Hangzhou, ZhejiangAges 18–80 - NCT06233526Recruiting
Personalized treatment for children with relapsed or resistant AML
This trial offers a personalized treatment plan for children with hard-to-treat or relapsed acute myeloid leukemia (AML). The plan is based on the unique genetic makeup of the child's cancer and lab tests that find the most effective drugs.
Hangzhou, ZhejiangAges Up to 18 years - NCT06281431Recruiting
Study comparing two needle types for nerve blocks to reduce pain
This trial compares a special echogenic (ultrasound-visible) needle with a standard needle for nerve blocks during surgery. The goal is to see which works better for preventing both short-term and long-term pain after operations like chest, abdomen, or limb surgeries.
Chongqing, Chongqing MunicipalityAges 18–70 - NCT06418698Recruiting
Brain artery calcium and clot removal outcomes
This study looks at whether calcium buildup in brain arteries affects how well clot removal (mechanical thrombectomy) works for stroke patients. You may be able to join if you have a large artery blockage, a CT scan was done, and you are having the clot removal procedure.
Guangzhou, GuangdongAges 18 years+ - NCT06840704RecruitingPhase 3
Can immunonutrition reduce esophagitis during lung cancer radiation?
This trial tests if a special nutritional supplement (immunonutrition) can lower the risk of severe throat and chest irritation (esophagitis) caused by radiation therapy for lung cancer. You may qualify if you are about to start chest radiation and can eat normally.
Changsha, HunanAges 18 years+ - NCT06928376RecruitingPhase 2
Venetoclax plus chemo vs standard chemo for AML
This trial tests a new combination of venetoclax plus a chemotherapy regimen (called CACAG) against a standard chemotherapy regimen (3+7) for adults with newly diagnosed intermediate- or high-risk AML. The goal is to see if the new combination works better.
Beijing, Beijing MunicipalityAges 14–75 - NCT07029178RecruitingPhase 2
Taurine for radiation mouth and skin sores
This trial tests if taurine can help reduce mouth sores and skin burns caused by radiation therapy for oral or throat cancer. You need to be starting a standard 30-session radiation course and have no other cancer treatments at the same time.
Shanghai, Shanghai MunicipalityAges 18–80 - NCT07262944Recruiting
Pain block study for ear surgery with rib cartilage
This study tests a pain-blocking injection during ear surgery to see if it helps reduce pain after the operation. It is for teenagers having ear reconstruction with rib cartilage at a specific hospital.
SeoulAges 13–18 - NCT07454226Recruiting
Drug combo for Ph-like acute lymphoblastic leukemia
This trial tests a combination of targeted drugs (ABL/JAK inhibitors) with chemotherapy and venetoclax for people with a type of leukemia called Ph-like ALL. It aims to see if this treatment is safe and effective.
Tianjin, Tianjin MunicipalityAges 14–60 - NCT07514650Recruiting
Citrate Blood Thinner Safety in Critical Kidney Care
This study tests whether a specific blood-thinning method using citrate works safely and effectively in critically ill patients whose kidneys have suddenly stopped working and need a special filtering machine. Researchers want to confirm that this approach prevents dangerous blood clots while keeping patients safe.
Barcelona, BarcelonaAges 18 years+ - NCT03720522Recruiting
Study brain-heart signals in acute stroke using MRI
This study looks at how the brain and heart interact right after an acute ischemic stroke. It may help doctors better understand what happens in the first hours of stroke and improve monitoring or future treatments.
Bern, Canton of BernAges 18–86 - NCT06084819RecruitingPhase 2
New drug combo for relapsed AML
This trial tests a new drug combination (venetoclax plus CACAG chemotherapy) for people whose acute myeloid leukemia has come back or not responded to earlier treatments. The goal is to see if this combination can help control the leukemia.
Beijing, Beijing MunicipalityAges 14–75 - NCT04881240RecruitingPhase 1
Donor-made memory T-cell therapy for hard-to-treat leukemia
This Phase 1 study tests an immune-cell therapy made from a matched donor to treat relapsed or refractory CD19-positive leukemia. It may help patients who have limited options, especially those who cannot receive the standard donor-cell or self-made (autologous) CD19 CAR T-cell therapy.
Memphis, TennesseeAges Up to 21 years - NCT05648019RecruitingPhase 2
CD19 CAR T-cell therapy for tough B-cell blood cancers
This Phase 2 study tests a one-time CAR T-cell treatment aimed at CD19, a target found on many B-cell leukemias and lymphomas. It’s for people whose disease has come back or hasn’t responded to prior treatments, or who can’t have a stem cell transplant.
SingaporeAges birth–70 years - NCT07651163Enrolling by invitationPhase 2/Phase 3
Comparing three chemotherapy regimens for newly diagnosed blood cancer
This trial tests three different chemotherapy regimens for adults 15–65 years old with newly diagnosed acute myeloid leukemia (AML)—a serious blood cancer. The goal is to see which treatment approach works best for patients with intermediate or high-risk disease who are fit enough for intensive chemotherapy.
Hangzhou, ZhejiangAges 15–65 - NCT06758609Recruiting
Brain cooling plus clot removal for large artery stroke
This trial tests a new treatment that combines cooling the brain with a catheter and removing the clot to restore blood flow — for people who have had a major stroke in the front part of the brain within the last 24 hours.
Guangzhou, GuangdongAges 18–85 - NCT06307392Recruiting
Bougie versus tube for first-attempt breathing tube success
This trial compares two methods of placing a breathing tube during a medical emergency outside the hospital: using a flexible device called a bougie versus just the tube alone. It aims to see which method is more successful on the first try.
Nantes, Loire AtlantiqueAges 18 years+ - NCT06868511RecruitingPhase 3
Minimally invasive clot removal with tenecteplase for deep brain bleed
This trial tests a minimally invasive procedure to remove deep brain bleeds using a special puncture guided by brain imaging, combined with a clot-dissolving drug called tenecteplase. It may help reduce damage from the bleed and improve recovery.
Beijing, ChinaAges 18–80 - NCT07712848RecruitingPhase 3
Comparing 3 drug combos for newly diagnosed AML
This trial tests whether a new combination (DEC3-VEN) works better than two other standard treatments for people with newly diagnosed acute myeloid leukemia (AML). The goal is to find the best initial therapy to help achieve remission.
Kunming, YunnanAges 18–65 - NCT04450758Recruiting
Stent or stoma right away versus surgery later for bowel blockage
This trial studies treatment choices for adults with a large-bowel blockage caused by colon cancer. It compares doing an emergency procedure now (like a stent or stoma) versus bridging to a later colon surgery, to see which approach is safer and works better.
GothenburgAges 18–100 - NCT04624295RecruitingPhase 4
Aspirin soon after certain bleeding stroke, after clot-busting therapy
This trial studies whether starting aspirin early is safe and helpful for people who, after clot-busting treatment for an ischemic stroke, develop a specific type of small brain bleeding called hemorrhagic infarction. You might benefit if your scan later shows this pattern of bleeding and you are not able to take blood-thinners or aspirin is safe for you.
HangzhouAges Any age
Hear when a new Acute Hospitalization trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for acute hospitalization?
- Yes. Clin2 currently lists 983 recruiting acute hospitalization studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a acute hospitalization trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a acute hospitalization trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.